PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Methanolic extracts from aerial parts and roots demonstrate in vitro and in vivo anti-inflammatory effects [PMID: 27721054]
A decoction of flowers inhibited the overall incidence of tumors in irradiated female rats [PMID: 27827272]
A decoction of meadowsweet showed inhibitory activity against mammary carcinogenesis induced by Methylnitrosourea [PMID: 29607788]
Postnatal administration of a decoction inhibited neurogenic and renal tumors induced by ethylnitrosourea [PMID: 27838807]
Isolated rutin from F. ulmaria normalized blood glucose levels and the HOMA-IR index [PMID: 41892152]
Evidence summary
PubMed sources
- 1.PMID: 36145820 (2022) — Study of the Antioxidant Properties of Filipendula ulmaria and Alnus glutinosa. · Plants (Basel, Switzerland)
- 2.PMID: 34681821 (2021) — Phytoconstituents and Bioactivity of Plants of the Genus Spiraea L. (Rosaceae): A Review. · International journal of molecular sciences
- 3.PMID: 37111776 (2023) — In Vitro Biotransformation and Anti-Inflammatory Activity of Constituents and Metabolites of Filipendula ulmaria. · Pharmaceutics
- 4.PMID: 27827272 (2017) — The inhibitory effect of meadowsweet (Filipendula ulmaria) on radiation-induced carcinogenesis in rats. · International journal of radiation biology
- 5.PMID: 34997711 (2021) — Variable neuroprotective role of Filipendula ulmaria extract in rat hippocampus.